OPN

Auto-Antibodies; Phosphatidylserine, Prothrombin, Phosphatidylserine/Prothrombin Complex

Product code
OPN
Device name
Auto-Antibodies; Phosphatidylserine, Prothrombin, Phosphatidylserine/Prothrombin Complex
Device class
Class 2
21 CFR
21 CFR 866.5660
Medical specialty
Immunology
Marketing pathway
510(K)
Flag
Third-party review eligible
510(k) clearances (all years, FDA)
1 (all years; only the last 3 years are listed here)

FDA classification definition

For the detection of autoantibodies to phosphatidylserine (PS), prothrombin (PT), or phosphatidylserine/prothrombin (PS/PT) complex in human serum or plasma. To aid in the diagnosis of certain autoimmune thrombotic disorders such as anti-phospholipid syndrome and those secondary to systemic lupus erythematosus or other lupus-like diseases

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: OPN
Classification and pathway per current FDA publications. Data from openFDA (CC0).